The online home of Neurology Reviews

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Treatment of Episodic Cluster Headache Deviates From Recommendations

Publish date:: August 27, 2019

Key clinical point: Additional options for the preventive treatment of episodic cluster headache may be needed.

Major finding: About 48% of patients use acute therapy only, and 48% use preventive treatments.

Study details: An analysis of data from the Adelphi 2017 Cluster Headache Disease Specific Programme, a cross-sectional survey.

Disclosures: Eli Lilly funded the study.

Citation:

Nichols R et al. AHS 2019. Abstract OR04.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Headache & Migraine

HIT-6 may help track meaningful change in chronic migraine,

Choroid plexuses may play a role in migraine,

Multiple traits more common in difficult-to-treat patients with migraine,

Marijuana for migraine? Some tentative evidence,

Low vitamin D levels in patients with migraine,